SARS-CoV-2 evades natural killer cell cytotoxic responses

In a recent study posted to the bioRxiv* preprint server, researchers at Stanford University School of Medicine revealed the mechanism via severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escapes natural killer (NK) cell cytotoxic reactions.

Biomedicines, Free Full-Text

Could Chimeric Antigen Receptor-NK Cell Therapy Be the Next Big Thing?

Natural Killer Cells: Taking on SARS-CoV-2

SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression

Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2

Generating natural killer cells for adoptive transfer: expanding horizons - Cytotherapy

SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

Natural killer cell specificity for viral infections

Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2

Infographic: How SARS-CoV-2 Immune Responses May Differ by Sex

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies